Jnba Financial Advisors Eli Lilly & CO Transaction History

Jnba Financial Advisors

  • $980 Million
  • Q3 2024

A detailed history of Jnba Financial Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Jnba Financial Advisors holds 499 shares of LLY stock, worth $393,306. This represents 0.05% of its overall portfolio holdings.

Number of Shares
499
Previous 499 -0.0%
Holding current value
$393,306
Previous $451,000 2.0%
% of portfolio
0.05%
Previous 0.05%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024
SELL
$724.87 - $909.04 $94,233 - $118,175
-130 Reduced 20.67%
499 $451,000
Q1 2024

Apr 26, 2024
BUY
$592.2 - $792.28 $135,613 - $181,432
229 Added 57.25%
629 $489,000
Q4 2023

Feb 07, 2024
SELL
$525.19 - $619.13 $60,922 - $71,819
-116 Reduced 22.48%
400 $233,000
Q3 2023

Nov 02, 2023
SELL
$434.7 - $599.3 $13,910 - $19,177
-32 Reduced 5.84%
516 $277,000
Q2 2023

Aug 03, 2023
BUY
$350.74 - $468.98 $1,402 - $1,875
4 Added 0.74%
548 $257,000
Q1 2023

May 01, 2023
BUY
$310.63 - $364.82 $1,242 - $1,459
4 Added 0.74%
544 $186,000
Q3 2022

Nov 07, 2022
SELL
$296.48 - $337.87 $17,492 - $19,934
-59 Reduced 9.85%
540 $175,000
Q2 2022

Jul 22, 2022
SELL
$278.73 - $327.27 $8,083 - $9,490
-29 Reduced 4.62%
599 $194,000
Q4 2021

Feb 03, 2022
BUY
$224.85 - $279.04 $19,786 - $24,555
88 Added 16.3%
628 $173,000
Q1 2021

May 03, 2021
BUY
$164.32 - $212.72 $4,929 - $6,381
30 Added 5.88%
540 $101,000
Q2 2020

Jul 24, 2020
SELL
$136.42 - $164.18 $27,283 - $32,836
-200 Reduced 28.17%
510 $84,000
Q1 2020

May 01, 2020
SELL
$119.05 - $147.35 $9,881 - $12,230
-83 Reduced 10.47%
710 $98,000
Q4 2019

Feb 10, 2020
BUY
$106.92 - $132.43 $20,635 - $25,558
193 Added 32.17%
793 $104,000
Q3 2019

Nov 01, 2019
SELL
$106.79 - $116.16 $21,358 - $23,232
-200 Reduced 25.0%
600 $67,000
Q2 2019

Jul 26, 2019
BUY
$110.79 - $129.32 $11,079 - $12,932
100 Added 14.29%
800 $89,000
Q4 2018

Feb 07, 2019
SELL
$105.9 - $118.64 $116,490 - $130,504
-1,100 Reduced 61.11%
700 $81,000
Q3 2018

Nov 01, 2018
BUY
$85.86 - $107.31 $94,446 - $118,041
1,100 Added 157.14%
1,800 $193,000
Q4 2017

Jan 31, 2018
SELL
$81.94 - $87.89 $24,582 - $26,367
-300 Reduced 30.0%
700 $59,000
Q3 2017

Nov 13, 2017
BUY
$77.07 - $85.54 $23,120 - $25,662
300 Added 42.86%
1,000 $86,000
Q2 2017

Aug 14, 2017
BUY
N/A
700
700 $58,000

Others Institutions Holding LLY

# of Institutions
4,007
Shares Held
752M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Jnba Financial Advisors Portfolio

Follow Jnba Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email